Possible arrhythmiogenic mechanism produced by ibuprofen

Acta Pharmacologica Sinica

Volumn 29, Issue 4, 2008, Pages 421-429

  Yang, Zhi Fang ^a   Wang, Hong Wei ^a   Zheng, Yan Qian ^a   Zhang, Yin ^a   Liu, Yuan Mou ^a   Li, Ci Zhen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Action potentials; Arrhythmias; Electrocardiogram; Ibuprofen

Indexed keywords

IBUPROFEN; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; QRS COMPLEX;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; GUINEA PIGS; HEART; IBUPROFEN; MALE; PAPILLARY MUSCLES;

EID: 41549139349     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00754.x     Document Type: Article

References (18)

1. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moyé L. Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994 15: 346 52.
2. Wu ZG, Zhou XL, Shu CM. Arrhythmia induced by the use of ibuprofen. Chin Foreign Med J 2005 3: 88 9.
3. Shi YL, Wang YZ, Zhao XL. One case of atrial fibrillation induced by ibuprofen. J Med Theor Prac 2004 17: 447.
4. Huerta C, Varas-Lorenzo C, Castellsague J, Garcia Rodriguez LA. Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart 2006 92: 1610 5.
5. Hudson M, Richard H, Pilote L. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. Br Med J 2005 300: 1370 3.
6. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemop prevention trial. N Engl J Med 2005 352: 1092 102.
7. 1 syndrome model. J Cardiovasc Electr 2004 15: 815 20.
8. Lu HL, Li CZ, Liu YM, Weng EQ, Liu B. The effects of Guanxinling on coronary blood flow-contraction force of cardiac muscle and electrical activity of the heart. Chin Heart J 2004 16: 323 6.
9. Buchanan FG, Holla V, Katkuri S, Matta P, Dubois RN. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for prevention and treatment of intestinal cancer. Cancer Res 2007 67: 9380 8.
10. Martinez-Gonzalez J, Badimon L. Mechanisms underlying the cardiovascular effects of Cox-inhibition: benefits and risks. Curr Pharm Res 2007 13: 2215 27.
11. Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005 365: 475 81.
12. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001 286: 954 9.
13. Leroy S, Mosca A, Landre-Peigne C, Cosson MA, Pons G. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr Adolesc Med 2007 3: 51 8.
14. Huang WF, Hsiao FY, Wen YW, Tsai YW. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Clin Ther 2006 28: 1827 36.
15. Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Norgard B, Friis S, et al. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 2005 165: 978 84.
16. Liu XK, Tosaki A, Engleman RM, Das DK. Salicylate reduces ventricular dysfunction and arrhythmias during reperfusion in isolated rat hearts. J Cardiovasc Pharm 1992 19: 209 15.
17. Liu XK, Tosaki, A, Engleman RM, Das DK. Reduction of postischaemic ventricular dysfunction and arrhythmias by trapping hydroxyl radicals with salicylic acid. Int J Tissue React 1993 15: 25 30.
18. Cheruku KK, Ghani A, Ahmad F, Pappas P, Silverman PR, Zelinger A, et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 2004 7: 13 8.